ecrin-mdr-crcClinical2018Colorectal NeoplasmsColorectal Cancer MetastaticColorectal NeoplasmsColorectal Cancer MetastaticInterventionalhttps://newmdr.ecrin.org/Study/2266355United States7SirolimusECRIN MDRCompletedfalseNab-rapamycin in Combo With FOLFOX & BEV as 1st Line Therapy in Patients With Advanced or Metastatic Colorectal CancerA phase 1/2 multi-center investigation of ABI-009 (nab-rapamycin) in combination with mFOLFOX6 and Bevacizumab as first-line therapy in patients with advanced or metastatic colorectal cancer2018-07-152266355NCT03439462